Search - tctmd.com

Displaying 61 - 80 of 197

Sort: Relevancy | Date

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Industry News

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

August 26, 2017

News Conference News ESC 2017

Underweight and Overlooked: Low BMI Patients May Be Highest-Risk Post-PCI

Shelley Wood

August 26, 2017

News Daily News

Lower Blood Pressure May Protect Against Cognitive Decline in Adults in Their 70s

Todd Neale

August 22, 2017

News Daily News

Closing the Mitral Gap: Early Pascal Experience Shows Promise for High-Risk MR Patients

Yael L. Maxwell

August 22, 2017

News Daily News

Poor Metabolic Health Raises Coronary Heart Disease Risk Regardless of BMI

Yael L. Maxwell

August 21, 2017

News Opinion Fellow Talk

Physical Fitness for Fellows: Better Late Than Never

Bhuvnesh Aggarwal, MD

August 18, 2017

News Daily News

CMS Reverses Its Course on Bundled Payments for MI, CABG

Caitlin E. Cox

August 16, 2017

News Daily News

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

Yael L. Maxwell

August 14, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

Michael O'Riordan

August 01, 2017

News Daily News

Boston Scientific Scraps Biodegradable Scaffold Program

Michael O'Riordan

August 01, 2017

News Industry News

STENTYS Completes Enrollment in the Study Assessing the Safety and Efficacy of Xposition S in Left Main Artery Lesions

July 28, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 27, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 26, 2017

News Daily News

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

L.A. McKeown

July 25, 2017

News Daily News

CV Risk Higher With Modestly Elevated Troponin Levels, but Clinical Relevance Remains Unclear

Todd Neale

July 24, 2017

News Daily News

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Leah Lawrence

July 24, 2017

News Daily News

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Shelley Wood

July 21, 2017

News Daily News

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

Todd Neale

July 20, 2017

Advertisement

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

Underweight and Overlooked: Low BMI Patients May Be Highest-Risk Post-PCI

Lower Blood Pressure May Protect Against Cognitive Decline in Adults in Their 70s

Closing the Mitral Gap: Early Pascal Experience Shows Promise for High-Risk MR Patients

Poor Metabolic Health Raises Coronary Heart Disease Risk Regardless of BMI

Physical Fitness for Fellows: Better Late Than Never

CMS Reverses Its Course on Bundled Payments for MI, CABG

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

Boston Scientific Scraps Biodegradable Scaffold Program

STENTYS Completes Enrollment in the Study Assessing the Safety and Efficacy of Xposition S in Left Main Artery Lesions

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

CV Risk Higher With Modestly Elevated Troponin Levels, but Clinical Relevance Remains Unclear

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content